Gum Acacia supplementation improves adiponectin levels and HbA1c/adiponectin ratio in women with type 2 diabetes: A randomized controlled trial
DOI:
https://doi.org/10.31989/ffhd.v15i3.1568Abstract
Background: Adiponectin contributes to the regulation of glucose homeostasis and lipid profiles and plays a role in maintaining average body weight. At high serum concentrations, adiponectin sensitizes cells to insulin and exerts favorable effects on type 2 diabetes patients. Gum Acacia (GA) has shown beneficial impacts on serum glucose and lipid profile in both humans and animals. This study aimed to test the effects of oral GA consumption on serum adiponectin levels, glycemic parameters, and the glycosylated hemoglobin/adiponectin ratio in diabetic women.
Methods: Seventy-three diabetic women (type 2) with an HbA1c ≥ 6.5% were participated in a randomized, double-blind, placebo-controlled clinical trial. The intervention group (34 patients) received 30.0 g per day of GA, whereas the control group (39 patients) received 5.0 g of placebo per day. The intervention period was 12 weeks. Participants were interviewed and examined clinically before, during and after the intervention. The parameters analyzed before and after the intervention were BMI, serum adiponectin, fasting blood glucose, HbA1c, and the HbA1c/adiponectin ratio.
Results: Before the intervention, the mean age was 49±1.1 years, BMI was 28.3±0.6 kg/m2, HbA1c was 8.8±0.3%, adiponectin was 5.4±0.12 µg/ml, and the HbA1c/Adiponectin ratio was 1.8±0.06. All baseline parameters showed nonsignificant differences between the intervention and placebo groups. Following GA administration, both BMI and HbA1c were significantly reduced by 2.5% and 3.8%, respectively. The mean serum adiponectin level significantly increased by 7.4% from baseline in the GA group. The mean change in the HbA1c/adiponectin ratio was 0.3 µg/ml following the intervention (P < 0.01). Compared to that in the placebo group, the HbA1c/adiponectin ratio significantly decreased by 16.6% from baseline in the GA group versus an insignificant increase of 25.2% in the placebo group.
Conclusions: Gum Acacia consumption improved the glycemic profile and increased the serum adiponectin concentration in diabetic women at a dosage of 30.0 g/day for three months. This study uniquely explores the impact of Gum Acacia (GA) on serum adiponectin levels and the HbA1c/adiponectin ratio in type 2 diabetic women. Demonstrating a significant increase in adiponectin and a reduction in the HbA1c/adiponectin ratio following GA supplementation, this study provides novel insights into GA's potential as a dietary intervention for improving glycemic control in diabetic populations.
Keywords: Gum Acacia, Adiponectin, Dietary intervention, Type 2 diabetes mellitus
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Functional Foods in Health and Disease
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request.
Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.